Gilead Sciences Inc (NASDAQ:GILD)

73.61
BATS BZX Real-Time Price
As of 3:53pm ET
 +0.83 / +1.14%
Today’s Change
64.27
Today|||52-Week Range
89.54
+2.75%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$94.3B

Company Description

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. It also offers other pharmaceutical products under the Letairis, Ranexa, AmBisome, and Zydelig brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Contact Information

Gilead Sciences, Inc.
333 Lakeside Drive
Foster City California 94404
P:(650) 574-3000
Investor Relations:
(650) 524-7792

Employees

Shareholders

Mutual fund holders46.82%
Other institutional34.67%
Individual stakeholders1.21%

Top Executives

John F. MilliganPresident, Chief Executive Officer & Director
Robin L. WashingtonCFO, Principal Accounting Officer & Executive VP
John G. McHutchisonChief Scientific Officer
Brett A. PletcherSecretary, Chief Compliance Officer & Executive VP
William A. LeeExecutive Vice President-Research